Katherine Stueland - Apr 26, 2023 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Executive Officer
Signature
/s/ Bridget Brown, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Apr 26, 2023
Transactions value $
$0
Form type
4
Date filed
4/27/2023, 07:41 PM
Previous filing
Mar 13, 2023
Next filing
May 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Award $0 +9.9M $0.00 9.9M Apr 26, 2023 Class A Common Stock 9.9M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 6.25% vest in quarterly installments over the four-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.